Learn about the role of HPV in cervical cancer
 
What's New

24. April 2014

FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer 

Expanded indication makes cobas® HPV Test the only test approved in U.S. that can be used instead of Pap in first-line primary screening in women 25 and older.

>more


07. April 2014

Roche acquires IQuum to strengthen offerings in molecular diagnostics

IQuum’s unique products will allow Roche to quickly enter the point of care segment of molecular diagnostics

>more


19. March 2014

Roche launches the cobas® Cdiff Test for detection of Clostridium difficile in markets accepting the CE mark 

New test expands menu for hospital-acquired infections testing on the cobas® 4800 System.

>more

 Diagnostic and Blood Screening Tests

 

Roche Molecular Diagnostics (RMD) offers a uniquely broad range of diagnostic and blood screening assays based on the company's Nobel prize-winning PCR technologies.

 

RMD's tests and automated platforms are focused in the areas of virology, blood screening, HPV, genomics and oncology, microbiology and sexually transmitted infections. > more

 Contact

Contact your local sales representative for detailed information, questions and ordering.

 

 

 Browse Our Products

 Related Links